Department of Laboratory Medicine, Nationwide Children’s Hospital, Columbus, Ohio 43205, USA.
J Clin Microbiol. 2011 Jul;49(7):2390-4. doi: 10.1128/JCM.00817-11. Epub 2011 May 4.
In October 2009, the Centers for Disease Control and Prevention recommended that clinical laboratories test all stools submitted for the detection of enteric bacterial pathogens for the presence of Shiga toxin-producing Escherichia coli (STEC). In order to do this, it is recommended that all stools be cultured for Escherichia coli O157:H7 on selective medium as well as that testing for the presence of Shiga toxin be done by immunoassay to detect non-O157 STEC (3). There are a variety of products that are FDA approved for detection of Shiga toxin. Further, it is recommended that Shiga toxin detection be done by testing overnight enrichment broth cultures of stools rather than directly examining stools for this toxin. This recommendation was made approximately 18 months ago. We have asked Mario Marcon of Nationwide's Children Hospital in Columbus, OH, to explain the rationale for his decision to follow this recommendation, while we have asked Deanna Kiska and Scott Riddell of Upstate University Hospital in Syracuse, NY, why these guidelines have not been adopted by their laboratory.
2009 年 10 月,疾病控制与预防中心建议临床实验室对所有提交的用于检测肠细菌病原体的粪便进行志贺毒素产生大肠杆菌(STEC)检测。为此,建议在选择性培养基上对所有粪便进行大肠杆菌 O157:H7 的培养,同时通过免疫测定检测志贺毒素的存在,以检测非 O157 STEC(3)。有多种产品已获得 FDA 批准用于检测志贺毒素。此外,建议通过检测粪便的过夜富集肉汤培养物来进行志贺毒素检测,而不是直接检查粪便中的这种毒素。这一建议大约是在 18 个月前提出的。我们已经请俄亥俄州哥伦布市 Nationwide's Children 医院的 Mario Marcon 解释他为何决定遵循这一建议,同时我们也请纽约州锡拉丘兹市 Upstate 大学医院的 Deanna Kiska 和 Scott Riddell 解释为何他们的实验室没有采用这些指南。